FindTrial
Sign In

Use of oral lactoferrin ( extracted from milk ) in ulcerative colitis.

Role of Oral Lactoferrin in the treatment of Mild to Moderate Ulcerative Colitis - A Pilot Randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074891
Enrollment
30
Registered
2024-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K519- Ulcerative colitis, unspecified

Interventions

Intervention1: Oral lactoferrin: Oral lactoferrin will be given to mild to moderate UC patients in doses of 1 gm /day in addition to standard medical therapy for 3 months and response will be analysed

Sponsors

IMS BHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all patients in above age group with mild to moderate ulcerative colitis defined by complete mayo score 3-10 and UCEIS score greater than 1 will be included in the study

Exclusion criteria

Exclusion criteria: patients requiring hospitalization or colectomy, patients having history of surgery for ulcerative colitis, patients having concomitant GI infections and patients who are not giving consent for the study are to be excluded

Design outcomes

Primary

MeasureTime frame
difference in treatment response in 2 groups, which is defined by decrease in complete mayo score by 3 pointsTimepoint: At baseline & 3 months—

Secondary

MeasureTime frame
difference in the mean change in levels of biochemical variables such as hemoglobin , CRP levels & fecal calprotectin levelsTimepoint: At baseline & 3 months time—

Countries

India

Contacts

Public ContactDawesh Prakash Yadav

IMS BHU, Varanasi

devesh.thedoc@gmail.com8130856563

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026